Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
6.60
-0.07 (-1.05%)
Sep 24, 2026, 11:48 AM EDT - Market open
Emergent BioSolutions Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 338 | 649 | 518 | 125 | 589 | 2,339 | |
Market Cap Growth | -22.46% | 25.32% | 315.99% | -78.86% | -74.81% | -50.75% |
Enterprise Value | 787 | 1,075 | 1,044 | 917 | 1,414 | 2,824 |
Last Close Price | 6.67 | 12.36 | 9.56 | 2.40 | 11.81 | 43.47 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 12.34 | - | - | - | 10.65 |
Forward PE | - | 4.16 | 12.57 | 20.50 | 51.15 | 7.19 |
PS Ratio | 0.44 | 0.87 | 0.50 | 0.12 | 0.53 | 1.32 |
PB Ratio | 1.00 | 1.24 | 1.07 | 0.19 | 0.43 | 1.45 |
P/TBV Ratio | 4.30 | 7.54 | - | 1.51 | 1.34 | 2.99 |
P/FCF Ratio | 3.98 | 4.14 | 14.47 | - | - | 24.34 |
P/OCF Ratio | 3.50 | 3.81 | 8.82 | - | - | 7.30 |
PEG Ratio | - | 13.20 | 13.20 | 13.20 | 11.76 | 0.21 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.03 | 1.45 | 1.00 | 0.87 | 1.26 | 1.59 |
EV/EBITDA Ratio | 3.40 | 5.14 | 19.55 | - | 90.08 | 5.60 |
EV/EBIT Ratio | 5.63 | 9.30 | - | - | - | 7.32 |
EV/FCF Ratio | 9.20 | 6.85 | 29.17 | - | - | 29.39 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.72 | 1.12 | 1.40 | 1.35 | 1.03 | 0.54 |
Debt / EBITDA Ratio | 2.53 | 2.79 | 12.66 | - | 90.85 | 1.72 |
Debt / FCF Ratio | 6.85 | 3.72 | 18.89 | - | - | 9.13 |
Net Debt / Equity Ratio | 1.31 | 0.72 | 1.19 | 1.18 | 0.56 | 0.19 |
Net Debt / EBITDA Ratio | 1.93 | 1.81 | 10.80 | -16.29 | 49.38 | 0.60 |
Net Debt / FCF Ratio | 5.22 | 2.41 | 16.11 | -2.97 | -5.17 | 3.13 |
Asset Turnover | 0.61 | 0.55 | 0.65 | 0.42 | 0.37 | 0.61 |
Inventory Turnover | 1.19 | 1.15 | 2.29 | 2.34 | 2.38 | 3.01 |
Quick Ratio | 2.69 | 2.19 | 1.56 | 0.47 | 0.66 | 2.29 |
Current Ratio | 5.42 | 5.01 | 3.69 | 1.04 | 0.99 | 3.40 |
Return on Equity (ROE) | -40.29% | 10.46% | -33.67% | -74.67% | -14.11% | 14.35% |
Return on Assets (ROA) | 6.93% | 5.33% | -2.03% | -4.21% | -2.23% | 8.26% |
Return on Invested Capital (ROIC) | 16.18% | 7.49% | -4.22% | -9.40% | -5.36% | 15.27% |
Return on Capital Employed (ROCE) | 14.10% | 9.70% | -4.30% | -14.30% | -5.60% | 14.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -51.70% | 8.10% | -36.80% | -610.73% | -35.91% | 9.39% |
FCF Yield | 25.12% | 24.15% | 6.91% | -207.11% | -25.44% | 4.11% |
Buyback Yield / Dilution | 5.35% | -6.98% | -3.52% | -2.20% | 7.39% | -0.56% |